VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 25 filers reported holding VASCULAR BIOGENICS LTD in Q1 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 798 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 798 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 798 | +2651.7% | 0.00% | – |
| Q4 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 29 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 29 | +123.1% | 0.00% | – |
| Q1 2018 | $0 | – | 13 | -7.1% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | +40.0% | 0.00% | – |
| Q1 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spectrum Planning & Advisory Services Inc. | 16,000 | $3,910 | 0.01% |
| CATALYST FINANCIAL PARTNERS LLC | 39,000 | $9,532 | 0.00% |
| MORGAN STANLEY | 211,111 | $51,595 | 0.00% |
| HBK Sorce Advisory LLC | 20,575 | $5,029 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 155,358 | $37,907 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 52,572 | $12,849 | 0.00% |
| TWO SIGMA ADVISERS, LP | 15,000 | $3,666 | 0.00% |
| Tower Research Capital LLC (TRC) | 937 | $229 | 0.00% |
| XTX Topco Ltd | 11,735 | $2,863 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $3 | 0.00% |